Navigation Links
Pancreatic Cancer Correlation to Type 2 Diabetes Drugs Januvia and Byetta, New Studies Find Possible Connection
Date:4/23/2013

(PRWEB) April 23, 2013

A recently released study from the University of California, Los Angeles showed evidence of increased pre-cancerous changes in diabetic patients using “Incretin Mimetics,” a type of Type-2 Diabetes medication, in which the drugs Byetta and Januvia both belong. Incretin is a natural hormone that your body produces to assist the release of insulin to lower blood sugar. Patients with Type-2 Diabetes have problems producing that hormone. Byetta and Januvia were created to put incretin mimetics into the body to act like incretin to prompt your pancreas to release the insulin when blood sugar is low (i). Visit the website of d’Oliveira and Associates for more information about these two drugs: Byetta and Januvia.

A study conducted by Alexandra Butler and Peter Butler of the University of California, Los Angeles tested twenty individuals with diabetes and showed a 40 percent increase in pancreatic cell growth (ii). The same study found that cell damage in the people treated with the type of therapy provided from Byetta and Januvia had the potential to evolve into cancer (ii).    Public Citizen, a Washington-based public advocacy group, stated that this information is in accord with the increasing reported to the U.S. Food and Drug Administration (FDA) that there is a higher correlation between patients with pancreatic cancer and those that are using these types of drugs, as compared to other diabetes drugs (ii).

An additional study published by the Journal of American Medical Association (JAMA) Internal Medicine discovered that Januvia and Byetta may double the patients’ risk of pancreatitis. The JAMA study showed that patients hospitalized with pancreatitis were twice as likely to be using Januvia or Byetta when compared to those that did not have pancreatitis. This is the first study to have solid numbers to prove the hazards of Byetta and Januvia (iii).

The FDA has been aware of the effects and how these drugs may damage the pancreas since 2009 for Januvia (iv) and since 2007 for Byetta (v). After pancreatitis caused six deaths, the FDA increased the warnings on Byetta’s drug label even though they could not determine the cause of pancreatitis in four of the death. However, the manufacturers of these drugs are still making a profit. Merck, Januvia’s manufacturer, had reported $4.1 billion in 2012 worldwide sales. Bristol-Myers, Byetta’s manufacturer reported that Byetta and its longer-acting version, Bydureon, had made $227 million in total sales in 2012 (ii).

Attorney Paul d’Oliveira stated that “I feel this new study sheds some light on whether these type 2 diabetes drugs are actually as safe as the manufacturers say they are. Hopefully this new study will force these manufacturers to take a closer look at the adverse reaction reports and consider whether these drugs should be pulled from the market.”

If after using Januvia or Byetta and find that you or someone you know has developed pancreatitis or pancreatic cancer, d'Oliveira & Associates recommends that anyone afflicted do thier research to find the best Januvia and/or Byetta lawyer you can as you may only have one chance to get justice. d'Oliveira & Associates is working with some of the more experienced dangerous durgs attorneys in the country who are filing lawsuits, and there is no fee until a settlement or award is obtained.

For a free consultation, call 1-800-992-6878 or visit their website at dmlaw.com.

Sources:
(i) http://diabetes.webmd.com/incretin-mimetics-for-type-2-diabetes
(ii) http://www.bloomberg.com/news/2013-03-22/diabetes-drugs-may-cause-damage-to-pancreas-study-finds.html
(iii) http://archinte.jamanetwork.com/article.aspx?articleid=1656537#RESULTS
(iv) http://www.fda.gov/downloads/Drugs/DrugSafety/UCM204269.pdf
(v) http://www.fda.gov/downloads/Drugs/DrugSafety/UCM191084.pdf

Read the full story at http://www.prweb.com/releases/2013/4/prweb10638086.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Byetta Pancreatic Cancer Allegation Lawsuits Offered through Resource4thePeople
2. Blood Test Might Spot Pancreatic Cancer Early, Study Finds
3. New metabolite-based diagnostic test could help detect pancreatic cancer early
4. Dana-Farber Scientists find potential loophole in pancreatic cancer defenses
5. Research suggests popular diabetes drugs can cause abnormal pancreatic growth in humans
6. IU researchers receive $3.2 million to develop, improve therapies for pancreatic cancer
7. Bitter melon juice prevents pancreatic cancer in mouse models
8. Cleveland Clinic study shows bariatric surgery restores pancreatic function by targeting belly fat
9. Molecular master switch for pancreatic cancer identified, potential predictor of treatment outcome
10. Clinical trial looks to improve pancreatic cancer survival rates
11. Blood Test Might Help Guide Pancreatic Cancer Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... Vighter established its ... time by providing Prehospital Trauma Life Support (PHTLS) course scholarships to four medics ... trauma education developed in cooperation with the American College of Surgeons to promote ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... Digital Scientists, ... excited to announce the opening of a Greenville, South Carolina location. The ... digital progress in Greenville. , “We’ve been working with South Carolina clients for years ...
(Date:3/24/2017)... ... March 24, 2017 , ... Texas Physical Therapy Specialists (TexPTS) is pleased ... Huebner Road. The clinic is the group’s 7th location in San Antonio and 23rd ... PT, will provide care from the clinic, which opened March 22, 2017. ...
(Date:3/24/2017)... ... March 24, 2017 , ... Shamanic healer and teacher ... Healing and Spiritual Awakening, proudly presents her Sacred Peru retreat with world ... and spiritual journey during the Summer Solstice will also be her final international ...
(Date:3/24/2017)... ... 2017 , ... Northridge dentists, Dr. Michel Elyson ... apnea and TMJ at their office. TMJ, or temporomandibular joint disorder, has long ... is increasingly being treated at dental offices with newly developed procedures and appliances. ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... -- Research and Markets has announced the addition of the ... to 2022" report to their offering. ... The global wound care market was worth $24,482.9 million ... 6.7% during 2016-2022 Among the various wound care products type, ... global market in 2015. Among the various applications, surgical wound segment held ...
(Date:3/24/2017)... Mar. 24, 2017 Research and Markets has announced ... report to their offering. ... This report analyzes the worldwide markets for Dental Implants in US$ ... Canada , Japan , Europe ... and Rest of World. Annual estimates and forecasts are ...
(Date:3/24/2017)... , March 24, 2017 ... providing high-quality and cost-effective drug development and ... pharmaceutical and biotechnology industry, announced today the ... ShangPharma will be consolidating the Contract ... (CMO) under Shanghai ChemPartner. These entities include ...
Breaking Medicine Technology: